LFWD · Lifeward Ltd. · Metrics
$5.50
-0.43 (-7.25%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, the Company incurred a consolidated net loss of $22.3 million and, as of June 30, 2026, had an accumulated deficit in the total amount of $307.1 million. The Company's cash and cash equivalents as of June 30, 2026 totaled $9.4 million and the Company's negative operating cash flow for the six months ended June 30, 2026 was $9.7 million. The Company expects to continue to generate operating losses and negative operating cash flows in the foreseeable future and will require additional funding to support its planned operations. These conditions raise substantial doubt about the Company's ability to continue as a going concern. ... Accordingly, the Company has concluded that substantial doubt exists about its ability to continue as a going concern for at least 12 months from the date of issuance of these consolidated financial statements.”View the 10-Q filed Aug 14, 2026
Market Cap
$16.79M
Shares
2.83M
Volume · Oct 20
1774
Avg daily vol (3M)
5748
LFWD metrics
61 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$5.93
Market cap
$16.79M
Price action
20 metricsPrice change (1W)
-4.7%
Price change (30D)
-15.3%
Price change (3M)
-21.5%
Price change (6M)
-21.1%
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
64.0%
Annualized volatility (3M)
49.7%
Beta
0.8
RSI (14D)
35.8
Price vs SMA 50
-15.0%
Price vs SMA 200
—
Avg volume (3M)
5,968
Relative volume
1.1
Average dollar volume
$41,771
Company
3 metricsSector
Healthcare
Industry
Medical Devices
Shares outstanding
2.83M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.8×
reciprocal yield 128.4%
P / book
1.4
reciprocal yield 71.9%
FCF yield
-100.6%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-181.4%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-05-15
Profitability
9 metricsGross margin
36.0%
Operating margin
-104.2%
Trailing 12 months
Net margin
-141.3%
Gross profit (TTM)
$7.85M
Operating profit (TTM)
−$22.75M
Net income (TTM)
−$30.83M
Trailing 12 months
Diluted EPS (TTM)
$-15.44
FCF margin
-78.3%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+15.7%
Year over year
Net income growth YoY
—
Revenue (TTM)
$21.82M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+198.9%
Year over year · more shares
Revenue CAGR (3Y)
+58.7%
Revenue CAGR (5Y)
+38.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-252.4%
Return on assets
-88.1%
Debt / equity
—
Current ratio
2.3
EBITDA (TTM)
—
Free cash flow (TTM)
−$17.10M
Quick ratio
1.8
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$9.45M
Total assets
$35.00M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$17.08M
Capital expenditures (TTM)
$19,000
R&D (TTM)
$9.16M
SG&A (TTM)
—
Stock compensation (TTM)
$780,000
R&D / revenue
42.0%
Stock compensation / revenue
3.6%
Ownership (13F)
9 metrics13F filers
9
13F filer change QoQ
+1
Institutional ownership
1.1%
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
1.0%
Active holders' share change QoQ
+130.0%
Holder tenure
9.0
Price vs estimated holder cost
+9.5%
Ownership (registered funds)
1 metricsIndex-fund ownership
0.0%
Short interest
3 metricsShort interest
3.4%
Latest settlement · 22.7 days to cover
Days to cover
22.7d
Short-squeeze score
55 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
Flagged